Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05316571 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Sitting Interruption and Whole-body Cardiovascular Health

Study acronym: SWITCH
StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial completed Enrollment target: estimated 56 to confirmed 58 · Primary and study completion dates changed from estimate of May 31, 2026 to May 30, 2026 · Eligibility criteria shortened, about 13 words · 4 more Show 7 more changesShow less
    • Enrollment target: estimated 56 to confirmed 58
    • Primary and study completion dates changed from estimate of May 31, 2026 to May 30, 2026
    • Eligibility criteria shortened, about 13 words
    • Secondary endpoints: details revised at 2 of 2 entries
    • Site details revised
    • Publications: details revised at 1 of 1 entry
    • Study description shortened, about 1 word
  2. Primary and study completion dates: Feb 28, 2026 to May 31, 2026v8
  3. Eligibility criteria revised Study description revised · Site contact updatedv7 Show 2 more changesShow less
    • Study description revised
    • Site contact updated

    See this version in full on ClinicalTrials.gov ↗

  4. Re-verified, no change to tracked fieldsv6
  5. Publications: details revised at 1 of 1 entryv5
Show 3 earlier versionsHide 3 earlier versions
  1. Start date changed from estimate of Jul 20, 2022 to Aug 15, 2022v4
  2. Trial status: Not Yet Recruiting to Recruiting Start date: Jun 2022 to Jul 20, 2022 · Site details revisedv3 Show 2 more changesShow less
    • Start date: Jun 2022 to Jul 20, 2022
    • Site details revised
  3. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
There is strong evidence for the association between sedentary behaviors and cardiovascular diseases such as coronary heart disease and stroke. However, the public currently has no clear guidance on how to limit or interrupt their sedentary behaviors. This study will identify and test the physiological effects of several sedentary behavior interruption strategies and explore the feasibility (i.e., likelihood of an individual performing the requested activities) of those strategies to inform the development of public policy surrounding sedentary behavior interruption. Long-term, the findings of this study will inform a large clinical trial that can test whether sedentary behavior reduction can decrease cardiovascular disease risk.
Trial Details
NCT Number NCT05316571
Lead Sponsor University of North Carolina, Chapel Hill
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)
Conditions Sedentary Behavior, Sedentary Time
Enrollment 58 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov